Moneycontrol
Get App
SENSEX NIFTY
you are here:

GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE159A01016 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info

BSE Live

Jan 20, 13:27
1625.25 -1.90 (-0.12%)
Volume
AVERAGE VOLUME
5-Day
23,015
10-Day
16,350
30-Day
17,906
2,205
  • Prev. Close

    1627.15

  • Open Price

    1632.00

1625.25

Today’s L/H

1646.20
1131.05

52 Wk L/H

1735.00
1301.75

L/U Price Band

1952.55
  • Bid Price (Qty.)

    1625.45 (4)

  • Offer Price (Qty.)

    1628.00 (1)

  •  VWAP

    1634.69
     Beta
    0.31
  • Market Depth (20 Jan 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    4 1625.45 1628.00 1
    9 1625.40 1628.90 6
    3 1625.35 1629.55 1
    3 1625.30 1629.60 9
    3 1625.20 1630.00 1
    6174 Total Total 6823
     Market Depth
    BUY 6174
    SELL 6823
    48%
    52%

NSE Live

Jan 20, 13:27
1625.70 -2.15 (-0.13%)
Volume
AVERAGE VOLUME
5-Day
156,765
10-Day
106,715
30-Day
71,408
16,032
  • Prev. Close

    1627.85

  • Open Price

    1630.00

1623.25

Today’s L/H

1647.00
1130.00

52 Wk L/H

1737.00
1302.30

L/U Price Band

1953.40
  • Bid Price (Qty.)

    1625.60 (9)

  • Offer Price (Qty.)

    1628.45 (16)

  •  VWAP

    1634.77
     Beta
    0.29
  • DELIVERY AVERAGES
    3-Day
    86.29%
    5-Day
    84.85%
    8-Day
    82.36%
    Deliverables
  • SMA VOLUME
    30
    1631.40
    50
    1637.66
    150
    1414.52
    200
    1382.32
    SMA
    1631.40

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Neutral
Moving Averages Neutral
Technical Indicators Neutral
Moving Averages Crossovers Neutral
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 1643.73 1659.62 1672.23 1631.12 1615.23 1602.62 1586.73
Fibonacci 1642.00 1648.73 1659.62 1631.12 1620.23 1613.50 1602.62
Camarilla 1630.46 1633.07 1635.69 1631.12 1625.24 1622.63 1620.01

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 1627.32
10 1629.64
20 1624.88
50 1637.77
100 1523.22
200 1383.95
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Valuation

    • Market Cap (Rs Cr.)
      27,672.48
    • P/E
      32.5
    • Book Value (Rs)
      126.47
    • Dividend (%)
      200.00
    • Market Lot
      1
    • Industry P/E
      31.15
    • EPS (TTM)
      50.31
    • P/C
      30.74
    • Price/Book
      12.92
    • Dividend Yield.(%)
      1.22
    • Face Value (RS)
      10.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      86.29
      5-Day
      84.85
      8-Day
      82.36
      87.89

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      27,672.48
    • P/E
      31.59
    • Book Value (Rs)
      126.31
    • Dividend (%)
      200.00
    • Market Lot
      1
    • Industry P/E
      31.15
    • EPS (TTM)
      51.76
    • P/C
      29.91
    • Price/Book
      12.93
    • Dividend Yield.(%)
      1.22
    • Face Value (RS)
      10.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      86.29
      5-Day
      84.85
      8-Day
      82.36
      87.89

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Forum

Community Sentiments

  • 100% BUY
  • 0% SELL
  • 0% HOLD
100%
of moneycontrol users recommend buying GlaxoSmithKline

What's your call on GlaxoSmithKline today?

Read 1 investor views

BUY SELL HOLD

Action in GlaxoSmithKline Pharmaceuticals Ltd.

Pre-Opening Session Prices9:00 am - 9:15 am

BSE - No shares traded

NSE

Jan 20, 09:15
1630.00 2.15 (0.13%)
High 1630.00
Low 1625.00
Prev. Close 1627.85

Financials

Income Statement

  Sep 2019 Jun 2019 Mar 2019 Dec 2018 Sep 2018
Net Sales 882.10 788.02 751.22 825.35 816.31
Other Income 15.61 30.54 52.46 16.42 14.82
PBDIT 194.24 165.48 163.63 137.32 165.16
Net Profit 502.79 113.46 123.03 112.97 100.77
  Sep 2019 Jun 2019 Mar 2019 Dec 2018 Sep 2018
Net Sales 882.02 787.97 751.13 825.03 816.31
Other Income 15.88 30.81 52.72 16.58 15.01
PBDIT 194.01 165.29 163.05 137.08 165.03
Net Profit 502.75 113.54 123.76 136.72 100.83

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 169.41 84.70
Networth 2,142.42 2,079.95
Total Debt 0.18 0.58
Net Block 431.61 324.57
Investments 24.55 47.67
Total Assets 2,142.59 2,080.52

On
Current Price %Gain / Loss
No Record Found
On
Current Price %Gain / Loss
No Record Found
to view the Open, High, Low, Close, Volume and Historic data for
Array

CORPORATE ACTION

Date Agenda
Feb 03, 2020 Quarterly Results
Oct 22, 2019 Quarterly Results
Jul 22, 2019 Quarterly Results
May 20, 2019 Audited Results & Dividend
Feb 04, 2019 Quarterly Results
Type Dividend% Ex-Dividend date
Final 200.00 Jul 11, 2019
Final 350.00 Jul 13, 2018
Final 300.00 Jul 14, 2017
Final 500.00 Jul 15, 2016
Final 625.00 Jul 23, 2015
Ratio Announcement Date Ex-Bonus
1:1 Jul 24, 2018 Sep 11, 2018
1:1 Sep 28, 1994 Jan 02, 1995
1:3 Jun 23, 1980 -
Old FV New FV Ex-Split
No Splits Information is available for GlaxoSmithKline Pharmaceuticals
Ratio Premium Ex-Bonus
1:5 55 May 21, 1993
Date Agenda
Jul 22, 2019 -
Sep 07, 2018 -
Jul 24, 2018 -
Jul 25, 2017 -
Jul 28, 2016 Rs.50.0000 per share(500%)Dividend

Dividend Summary

For the year ending March 2019 GlaxoSmithKline Pharmaceuticals has declared an equity dividend of 200.00% amounting to Rs 20 per share. At the current share price of Rs 1625.70 this results in a dividend yield of 1.23%.

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone September 2019 June 2019 March 2019 December 2018
Promoters 75 75 75 75
Pledged 0 0 0 0
FII/FPI 0.54 1.35 1.45 1.47
Total DII 13.56 12.84 12.7 12.62
Fin.Insts 7.52 8.13 8.16 8.2
Insurance Co 0 0 0 0
MF 3.45 3 2.92 2.81
Others DIIs 2.59 1.71 1.62 1.61
Others 10.91 10.82 10.85 10.9
Total 100.01 100.01 100 99.99

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
GlaxoSmithKline 1625.25 -0.12 1735.00 1131.05 27532.72 3,128.53 425.36
Sun Pharma 449.60 -1.07 484.10 350.40 107874.1 10,303.21 816.60
Dr Reddys Labs 3071.35 1.24 3072.90 2065.30 51033.96 10,625.50 1,277.30
Divis Labs 1900.35 -0.16 1925.25 1460.55 50448.32 4,879.66 1,332.65
Cipla 481.05 0.17 585.50 389.55 38783.58 12,374.01 1,888.41

COMPANY OVERVIEW

GlaxoSmithKline Pharmaceuticals Ltd. (GSK Rx India) is one of the oldest pharmaceuticals company. The GSK India product portfolio includes prescription medicines and vaccines. Their prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases. The company is the market leader in most of the therapeutic categories in which it operates. GSK also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others.

COMPANY INFORMATION

Data not available

About GlaxoSmithKline Pharmaceuticals Ltd.

GlaxoSmithKline is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 500660 and the NSE with an NSE Code of GLAXO.

Related Searches